Skip to main content
. 2014 Sep 30;15:102. doi: 10.1186/s12863-014-0102-y

Table 2.

Genotype frequencies in Tajiks compared with four other populations

SNP ID Gene Category Allele Tajik genotype frequencies p values against four populations (after Bonferroni correction)
Family Phase A B AA(%) AB(%) BB(%) CHB JPT CEU YRI
rs1045642 ABCB1 ABC transporters others T C 34.3 45.5 20.2 8.49E-03 3.42E-02 3.10E-01 2.17E-18
rs1128503 ABCB1 ABC transporters others T C 32.3 51.5 16.2 3.09E-02 8.73E-01 1.69E-02 3.03E-19
rs2032582 ABCB1 ABC transporters others G T 18 49.4 32.6 9.02E-01 6.07E-01 8.24E-02 -
rs975833 ADH1A alcohol dehydrogenase phase I G C 55.6 37.4 7.1 4.86E-16 3.45E-14 6.46E-01 5.79E-01
rs1229984 ADH1B alcohol dehydrogenase phase I G A 48 45 7 3.76E-12 7.23E-11 9.18E-11 1.26E-10
rs2066702 ADH1B alcohol dehydrogenase phase I C T 95 5.1 0 2.97E-01 2.97E-01 1.94E-01 1.61E-11
rs698 ADH1C alcohol dehydrogenase phase I A G 44.3 45.4 10.3 1.21E-09 3.22E-09 1.24E-02 7.40E-11
rs1801252 ADRB1 adrenergic receptors others G A 3 34.3 62.6 1.22E-05 1.52E-05 - 2.53E-06
rs1801253 ADRB1 adrenergic receptors others C G 63.6 32.3 4 6.12E-01 3.88E-01 5.87E-02 4.12E-04
rs1042713 ADRB2 adrenergic receptors others G A 36 49 15 4.49E-03 5.67E-01 7.34E-01 6.05E-02
rs1042714 ADRB2 adrenergic receptors others G C 14 40 46 1.26E-03 3.39E-05 2.70E-02 9.85E-03
rs2066853 AHR AHR others G A 69 27 4 1.18E-05 7.65E-08 6.87E-02 9.06E-08
rs4680 COMT COMT phase II A G 31 45 24 9.95E-05 1.56E-05 5.25E-01 3.15E-05
rs28399454 CYP2A6 cytochrome P450 phase I G / 100 0 0 - - 1.00E + 00 7.81E-07
rs3745274 CYP2B6 cytochrome P450 phase I G T 46 36 18 1.07E-03 2.03E-03 5.17E-02 1.50E-01
rs28399499 CYP2B6 cytochrome P450 phase I T / 100 0 0 - - - 2.04E-06
rs4244285 CYP2C19 cytochrome P450 phase I G A 85 15 0 1.00E-03 1.56E-05 4.07E-02 8.50E-02
rs1799853 CYP2C9 cytochrome P450 phase I C T 100 0 0 - - 6.25E-05 -
rs776746 CYP3A5 cytochrome P450 phase I G A 81 17 2 2.78E-05 8.74E-05 2.58E-02 1.23E-34
rs10264272 CYP3A5 cytochrome P450 phase I C / 100 0 0 1.00E + 00 1.00E + 00 - 8.95E-09
rs6277 DRD2 G-protein-coupled receptor others G A 38 47 15 7.41E-08 1.01E-07 1.98E-02 6.51E-11
rs1800497 DRD2 G-protein-coupled receptor others T C 3.1 29.6 67.4 8.59E-06 1.43E-05 7.19E-01 2.25E-06
rs1695 GSTP1 glutathione S-transferase phase II A G 59 36 5 5.70E-01 1.96E-03 2.32E-04 1.50E-03
rs1138272 GSTP1 glutathione S-transferase phase II T C 0 18 82 3.00E-03 2.00E-03 9.22E-01 2.28E-03
rs3846662 HMGCR HMGCR phase I T C 18 61 21 2.49E-01 7.26E-01 2.12E-02 2.79E-24
rs3807375 KCNH2 eag others A G 19 48 33 6.73E-07 8.34E-12 4.02E-01 1.13E-11
rs3815459 KCNH2 eag others A G 16 49 35 6.04E-06 2.69E-09 - 6.88E-01
rs1801131 MTHFR methylenetetrahydrofolate reductase phase I C A 7 56 37 9.07E-03 5.46E-04 2.32E-01 7.36E-09
rs1801133 MTHFR methylenetetrahydrofolate reductase phase I T C 4 30.3 65.7 3.13E-07 1.21E-03 1.92E-02 9.34E-03
rs3814055 NR1I2 nuclear receptor others C T 30 56 14 8.60E-03 2.15E-03 1.00E-01 1.32E-03
rs701265 P2RY1 G-protein coupled receptor others G A 4 32 64 7.61E-02 3.04E-01 9.33E-01 2.96E-25
rs2046934 P2RY12 G-protein coupled receptor others T C 82 16 2 5.69E-02 4.97E-02 4.49E-03 6.23E-03
rs20417 PTGS2 nuclear receptor others G C 97 0 3 5.43E-04 1.57E-03 3.65E-07 4.82E-17
rs689466 PTGS2 nuclear receptor others A G 73.7 23.2 3 3.68E-11 4.34E-07 7.13E-01 1.12E-01
rs1805124 SCN5A sodium channel gene others G A 9 40 51 1.23E-04 7.59E-04 7.80E-03 4.96E-01
rs6791924 SCN5A sodium channel gene others G / 100 0 0 - - - 2.00E-03
rs7626962 SCN5A sodium channel gene others G / 100 0 0 - - - 1.24E-03
rs1051266 SLC19A1 solute carrier others G A 29.9 51.6 18.6 3.65E-01 8.28E-02 8.36E-01 2.83E-06
rs4149056 SLCO1B1 solute carrier others T C 82 17 1 2.30E-01 7.68E-01 1.47E-01 2.66E-04
rs4124874 UGT1A10 UDP-glucuronosyltransferase phase II C A 14.4 56.7 28.9 1.64E-02 6.88E-02 3.31E-01 2.73E-23
rs4148323 UGT1A10 UDP-glucuronosyltransferase phase II A G 0 7 93 7.23E-08 3.22E-03 9.00E-02 9.00E-02
rs10929302 UGT1A10 UDP-glucuronosyltransferase phase II G A 53 41 6 2.58E-03 3.31E-03 9.38E-01 4.91E-02
rs1540339 VDR nuclear receptor others G A 47.5 39.4 13.1 1.60E-10 1.42E-11 7.78E-01 1.80E-02
rs1544410 VDR nuclear receptor others G A 40 52 8 3.05E-12 2.03E-06 1.75E-02 2.50E-01
rs2239179 VDR nuclear receptor others A G 31 51 18 4.01E-04 6.14E-05 3.63E-02 8.58E-03
rs2239185 VDR nuclear receptor others T C 22 58 20 2.86E-04 1.55E-01 - 4.37E-01
rs3782905 VDR nuclear receptor others C G 46 48 6 1.20E-01 6.72E-04 3.92E-01 7.74E-02
rs7975232 VDR nuclear receptor others C A 20 58 22 9.30E-05 2.13E-03 1.92E-02 2.44E-02
rs10735810 VDR nuclear receptor others C T 48.4 36.3 15.4 8.17E-02 8.74E-01 2.72E-01 4.64E-03
rs11568820 VDR nuclear receptor others G A 60.6 33.3 6.1 1.12E-04 4.25E-05 6.86E-01 8.35E-38
rs7294 VKORC1 VKORC1 phase I C T 44 46 10 8.00E-10 1.09E-06 7.69E-01 1.59E-04
rs9934438 VKORC1 VKORC1 phase I G A 26 49 25 1.29E-17 4.64E-14 1.01E-01 9.39E-25